Meteorin-like Protein and Zonulin in Polycystic Ovary Syndrome: Exploring Associations with Obesity, Metabolic Parameters, and Inflammation

被引:4
作者
Kabakchieva, Plamena [1 ]
Gateva, Antoaneta [2 ]
Velikova, Tsvetelina [3 ]
Georgiev, Tsvetoslav [4 ]
Yamanishi, Kyosuke [5 ,6 ]
Okamura, Haruki [5 ]
Kamenov, Zdravko [2 ]
机构
[1] Naval Hosp, Mil Med Acad, Clin Internal Med, Varna 9010, Bulgaria
[2] Med Univ Sofia, Univ Hosp Alexandrovska, Med Fac, Dept Internal Med,Clin Endocrinol, Sofia 1431, Bulgaria
[3] Sofia Univ St Kliment Ohridski, Med Fac, Sofia 1504, Bulgaria
[4] Med Univ Varna, Fac Med, Dept Internal Med 1, Clin Rheumatol,Univ Hosp St Marina, Varna 9010, Bulgaria
[5] Hyogo Med Univ, Dept Psychoimmunol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan
[6] Hyogo Med Univ, Dept Psychiat, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan
关键词
polycystic ovary syndrome; meteorin-like protein; zonulin; obesity; insulin resistance; INSULIN-RESISTANCE; ADIPOSITY; LEVEL;
D O I
10.3390/biomedicines12010222
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: Polycystic ovary syndrome (PCOS) is a prevalent hormonal and metabolic disorder, wherein the adipose tissue and gut microbiome have been demonstrated to contribute to its pathogenesis. This study aims to assess the concentrations of the adipokine, meteorin-like protein (Metrnl) and the protein, zonulin, related to intestine permeability, in individuals with PCOS with a particular emphasis on their relationship with obesity, clinical manifestations, hormonal profiles, and metabolic parameters. Methods: A cohort comprising 58 women with PCOS, classified according to the Rotterdam criteria, was enrolled. The study also considered age, body mass index (BMI), and ethnicity-matched controls (n = 30). Comprehensive anthropometric and clinical evaluations, hormonal assays, and biochemical analyses were conducted during the follicular phase. Subsequent subgroup analyses were executed within the PCOS cohort based on waist-to-height ratio (WHtR), insulin resistance (IR), and free androgen index (FAI). Serum concentrations of Metrnl and zonulin were quantified via the enzyme-linked immunosorbent assay (ELISA) technique. Results: The Metrnl and zonulin levels exhibited no significant disparity between PCOS patients and controls. Nevertheless, within the entire participant cohort and the PCOS group exclusively, overweight/obese participants demonstrated higher Metrnl concentrations relative to their normal-weight counterparts (p < 0.001, p = 0.001, respectively). Furthermore, higher Metrnl concentrations were identified in subgroups characterized by high WHtR and IR in comparison to those with low WHtR (p = 0.001) and without IR (p = 0.001), respectively. A correlation emerged between Metrnl levels and various anthropometric and metabolic parameters, as well as sex-hormone-binding globulin (SHBG) and interleukin-18 (IL-18) within the PCOS group. Multiple linear regression analysis identified HOMA-IR as the sole independent predictor of Metrnl levels. Conclusion: While Metrnl and zonulin levels do not serve as diagnostic indicators of PCOS, elevated Metrnl concentrations exhibited robust associations with proinflammatory and metabolic irregularities within the PCOS population.
引用
收藏
页数:11
相关论文
共 50 条
[21]   Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome [J].
Sagodi, Laszlo ;
Lombay, Bela ;
Vamosi, Ildiko ;
Barkai, Laszlo .
ORVOSI HETILAP, 2013, 154 (31) :1226-1234
[22]   Meteorin-like/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies [J].
Li, Zhuoqi ;
Gao, Ziyu ;
Sun, Tao ;
Zhang, Shipeng ;
Yang, Shengnan ;
Zheng, Meilin ;
Shen, Hui .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[23]   Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome [J].
Maliqueo, Manuel ;
Echiburu, Barbara ;
Crisosto, Nicolas ;
Amigo, Pablo ;
Aranda, Pablo ;
Sanchez, Fernando ;
Sir-Petermann, Teresa .
FERTILITY AND STERILITY, 2009, 92 (01) :277-282
[24]   Obesity in relation to clinical, endocrine and metabolic parameters in infertile women with polycystic ovary syndrome: the South Asian perspective [J].
Ishrat, Shakeela ;
Hossain, Marufa .
BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2021, 20 (04) :864-870
[25]   Racial and Ethnic Differences in Metabolic Disease in Adolescents With Obesity and Polycystic Ovary Syndrome [J].
Andrisse, Stanley ;
Garcia-Reyes, Yesenia ;
Pyle, Laura ;
Kelsey, Megan M. ;
Nadeau, Kristen J. ;
Cree-Green, Melanie .
JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (04)
[26]   When IGF-1 Meets Metabolic Inflammation and Polycystic Ovary Syndrome [J].
Li, Xiushen ;
Lin, Sailing ;
Yang, Xiaolu ;
Chen, Can ;
Cao, Shu ;
Zhang, Qi ;
Ma, Jingxin ;
Zhu, Guli ;
Fang, Qiongfang ;
Zheng, Chunfu ;
Liang, Weizheng ;
Wu, Xueqing .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138
[27]   The impact of insulin resistance on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome [J].
Yildizhan, Begum ;
Ilhan, Gokce Anik ;
Pekin, Tanju .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 36 (07) :893-896
[28]   Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index [J].
Dong, Zhe ;
Huang, Jia ;
Huang, Lili ;
Chen, Xiaoli ;
Yin, Qianqian ;
Yang, Dongzi .
JOURNAL OF DERMATOLOGY, 2013, 40 (03) :188-192
[29]   Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic Community Health Study/Study of Latinos [J].
Rao, Hridya C. ;
Meyer, Michelle L. ;
Kominiarek, Michelle A. ;
Daviglus, Martha L. ;
Gallo, Linda C. ;
Cordero, Christina ;
Syan, Raveen ;
Perreira, Krista M. ;
Talavera, Gregory A. ;
Fernandez-Rhodes, Lindsay .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 (05) :1384-1397
[30]   Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity [J].
Neven, Adriana C. H. ;
Mousa, Aya ;
Boyle, Jacqueline A. A. ;
Teede, Helena J. J. .
FRONTIERS IN ENDOCRINOLOGY, 2023, 13